Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Convenience Sampling Method

Convenience Sampling Method

Sampling is a technique to select a portion (or subset) of the larger population and study that portion (the sample) to gain information about the population. Data are the result of sampling from a population. The sampling method ensures that samples are drawn without bias and accurately represent the population.
Convenience sampling is a non-random method of sample selection; this method selects individuals that are easily accessible and may result in biased data. For example, a marketing...

Pharmaceutical Equivalents

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

X-ray Crystallography-Guided Design and Synthesis of Cyclopentyl Heteroaryl Carboxylic Acid-Based Inhibitors of the SARS-CoV-2 Nsp3 Macrodomain (Mac1).

Journal of medicinal chemistry·2026

Same author

Expediated synthesis of <i>N</i>-acyl-<i>N</i>-alkyl sulfonamide probes for protein proximity labelling.

Organic & biomolecular chemistry·2026

Same author

Towards all optically powered miniature devices in remote locations of the body.

Optics letters·2026

Same author

Design, modular synthesis and screening of 58 shape-diverse 3-D fragments.

Chemical science·2025

Same author

Patients' Priorities and Goals of Care During Intensive Care Unit Recovery: A Multicenter Cohort Study.

American journal of critical care : an official publication, American Association of Critical-Care Nurses·2025

Same author

Synthesis of a macrocyclic and medium-sized ring lactam library using cascade ring expansion reactions.

Organic & biomolecular chemistry·2025

Search research articles

Video Experimental Relacionado

Updated: Jun 29, 2026

Taste Exam: A Brief and Validated Test

Taste Exam: A Brief and Validated Test

Published on: August 17, 2018

Un sustituto de la espartina (+) fácilmente accesible.

Michael J Dearden¹, Catherine R Firkin, Jean-Paul R Hermet

¹Department of Chemistry, University of York, Heslington, York YO10 5DD, U.K.

Journal of the American Chemical Society

|October 3, 2002

Resumen

Una nueva diamina quiral, sintetizada a partir de (-) -citisina, muestra una selectividad enantiocomplementaria a la (-) -sparteína en transformaciones asimétricas. Este hallazgo ofrece nuevas posibilidades para la síntesis quiral y el desarrollo de catalizadores.

Más Videos Relacionados

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

Published on: November 2, 2019

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli

Published on: March 24, 2023

Videos de Experimentos Relacionados

Last Updated: Jun 29, 2026

Taste Exam: A Brief and Validated Test

Taste Exam: A Brief and Validated Test

Published on: August 17, 2018

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

PeptiQuick, a One-Step Incorporation of Membrane Proteins into Biotinylated Peptidiscs for Streamlined Protein Binding Assays

Published on: November 2, 2019

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli

Detection of Horizontal Gene Transfer Mediated by Natural Conjugative Plasmids in E. coli

Published on: March 24, 2023

Área de la Ciencia:

Química orgánica es la química orgánica.
Síntesis asimétrica de síntesis.
La catálisis por catálisis.

Sus antecedentes:

Las diaminas quirales son ligandos cruciales en la catálisis asimétrica.
(-) - Esparteína es un ligando de diamina quiral bien establecido.
El desarrollo de nuevos ligandos quirales con selectividad complementaria es de gran interés.

Objetivo del estudio:

Para sintetizar una nueva diamina quiral derivada de la (-) citisina.
Para evaluar el rendimiento de esta nueva diamina en transformaciones asimétricas.
Para comparar su enantioselectividad con la de la (-) -sparteína.

Principales métodos:

Síntesis en tres pasos de la diamina quiral objetivo a partir de (-) -citisina.
Evaluación en cuatro transformaciones asimétricas distintas.
Análisis de la enantioselectividad y comparación con la (-) -sparteína.

Principales resultados:

La nueva diamina quiral fue sintetizada con éxito.
Mostró una alta enantioselectividad en todas las reacciones asimétricas probadas.
La selectividad observada fue enantiocomplementaria a la de la (-) -sparteína.

Conclusiones:

La nueva diamina quiral es una alternativa viable a la (-) -sparteína.
Proporciona acceso al enantiómero opuesto en síntesis asimétrica.
Esta investigación amplía el conjunto de herramientas para la catálisis asimétrica.